Loading...
•
Dec 31, 2023
Glaukos Q4 2023 Earnings Report
Glaukos's Q4 2023 earnings were announced, featuring record net sales and advancements in their pipeline.
Key Takeaways
Glaukos Corporation reported record net sales of $82.4 million for Q4 2023, a 16% increase year-over-year. The company reaffirmed its 2024 net sales guidance of $350 million to $360 million.
Record net sales of $82.4 million in Q4 2023, up 16% year-over-year.
Glaucoma net sales reached $60.6 million, a 15% increase year-over-year.
Corneal Health net sales were $21.8 million, reflecting a 19% year-over-year growth.
Gross margin was approximately 77%, with a non-GAAP gross margin of about 84%.
Glaukos
Glaukos
Glaukos Revenue by Segment
Revenue by Segment
Glaucoma Revenue
CapyFin.com Forward Guidance
The company expects 2024 net sales to be in the range of $350 million to $360 million.